PHARMACYCLICS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 91 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-27: Reporting owner Hemmi Gregory; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-27: Reporting owner Hemmi Gregory; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-26: Reporting owner Hemmi Gregory; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-20: Reporting owner Loury David J; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-27 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,900 0 owned after | $4.47 exercise price | 2012-12-27 | |
| 2012-12-27 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 0 owned after | $11.21 exercise price | 2012-12-27 | |
| 2012-12-26 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 9,900 owned after | $4.47 exercise price | 2012-12-27 | |
| 2012-12-20 | Loury David J Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,469 25,531 owned after | $4.16 exercise price | 2012-12-21 | |
| 2012-12-18 | Erdtmann Rainer M Officer (VP, IR Education Training) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −59,558 206,000 owned after | $0.91 exercise price | 2012-12-18 | |
| 2012-12-17 | Erdtmann Rainer M Officer (VP, IR Education Training) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −34,442 265,558 owned after | $0.91 exercise price | 2012-12-18 | |
| 2012-12-17 | Buggy Joseph J Officer (VP, Research) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 101,000 owned after | $0.75 exercise price | 2012-12-17 | |
| 2012-11-09 | Mehta Minesh Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-11-09 | HALVORSON ERIC H Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-11-09 | Smith David Duane Director | 4 | Stock Option (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-11-09 | Booth Robert F. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-11-09 | Clark Kenneth A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-11-09 | van den Broek Richard Director | 4 | Stock Option (Right to But) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $49.00 exercise price | 2012-11-13 | |
| 2012-10-26 | Fardis Maria Officer (EVP, Operations and Alliances) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | Gayko Urte Officer (VP, Regulatory Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | McGreivy Jesse Officer (VP, Clinical Science) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | Clow Fong Wang Officer (VP Biostatistics Data Mgmt) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | Tan Heow Officer (EVP Global Mfg, Tech Ops & Edu) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | Brumm Joshua T Officer (EVP, Finance) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-26 | Zanganeh Maky Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $61.60 exercise price | 2012-10-29 | |
| 2012-10-02 holding as of filing | Gayko Urte Officer (VP, Regulatory Affairs) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $61.06 exercise price | 2012-10-02 | ||
| 2012-10-01 | van den Broek Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +510 510 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-10-01 | Mehta Minesh Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +267 267 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-10-01 | Hardiman Roy C. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +409 409 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-10-01 | HALVORSON ERIC H Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +466 466 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-10-01 | Smith David Duane Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +431 431 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-10-01 | Booth Robert F. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +442 442 owned after | $65.56 exercise price | 2012-10-03 | |
| 2012-09-28 holding as of filing | Clow Fong Wang Officer (VP Biostatistics Data Mgmt) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.49 exercise price | 2012-09-28 | ||
| 2012-09-28 holding as of filing | Clow Fong Wang Officer (VP Biostatistics Data Mgmt) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.20 exercise price | 2012-09-28 | ||
| 2012-09-28 holding as of filing | Clow Fong Wang Officer (VP Biostatistics Data Mgmt) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.63 exercise price | 2012-09-28 | ||
| 2012-09-27 holding as of filing | Anderson Cynthia Officer (VP, Clinical Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.99 exercise price | 2012-09-27 | ||
| 2012-09-27 holding as of filing | McGreivy Jesse Officer (VP, Clinical Science) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $25.33 exercise price | 2012-09-27 | ||
| 2012-09-27 holding as of filing | Fardis Maria Officer (EVP, Operations and Alliances) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.84 exercise price | 2012-09-27 | ||
| 2012-09-27 holding as of filing | Fardis Maria Officer (EVP, Operations and Alliances) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.63 exercise price | 2012-09-27 | ||
| 2012-09-27 holding as of filing | Fardis Maria Officer (EVP, Operations and Alliances) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.71 exercise price | 2012-09-27 | ||
| 2012-09-27 holding as of filing | Huh Christine Officer (VP, Human Resources) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.91 exercise price | 2012-09-27 | ||
| 2012-08-09 | Sjovall Boultbee Paula S Officer (EVP, Sales and Marketing) | 4 | Stock Option (Right to Buy) Derivative · Indirect · By Spouse | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $57.16 exercise price | 2013-11-06 | |
| 2012-08-09 | Brumm Joshua T Officer (EVP, Finance) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $57.16 exercise price | 2012-08-13 | |
| 2012-07-30 holding as of filing | Shearer Scott T Officer (VP, Global Quality) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $30.46 exercise price | 2012-07-30 | ||
| 2012-07-30 holding as of filing | Sjovall Boultbee Paula S Officer (EVP, Sales and Marketing) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $25.94 exercise price | 2012-07-30 | ||
| 2012-07-30 holding as of filing | Tan Heow Officer (SVP Global Mfg & Technical Ops) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $27.05 exercise price | 2012-07-30 | ||
| 2012-07-30 holding as of filing | Love Richard B Officer (Vice President, Legal) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $32.38 exercise price | 2012-07-30 | ||
| 2012-07-02 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +515 515 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-07-02 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +427 427 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-07-02 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +208 208 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-07-02 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +453 453 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-07-02 | HALVORSON ERIC H Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +515 515 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-07-02 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +440 440 owned after | $59.28 exercise price | 2012-07-05 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,922 0 owned after | $6.63 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,777 0 owned after | $6.75 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,754 0 owned after | $8.12 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $5.76 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,185 0 owned after | $6.52 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −124 0 owned after | $6.01 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,204 0 owned after | $10.58 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,126 0 owned after | $11.31 exercise price | 2012-05-21 | |
| 2012-05-17 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −973 0 owned after | $15.02 exercise price | 2012-05-21 | |
| 2012-05-08 | Hemmi Gregory Officer (VP Chemical Operations) | 4 | Employye Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $4.25 exercise price | 2012-11-02 | |
| 2012-04-02 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,052 1,052 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-04-02 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,183 1,183 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-04-02 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +683 683 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-04-02 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +802 802 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-04-02 | HALVORSON ERIC H Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +824 824 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-04-02 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800 800 owned after | $28.47 exercise price | 2012-04-04 | |
| 2012-02-13 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 4,000 owned after | $2.30 exercise price | 2012-02-15 | |
| 2012-02-13 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,286 0 owned after | $1.94 exercise price | 2012-02-15 | |
| 2012-02-13 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 0 owned after | $2.90 exercise price | 2012-02-15 | |
| 2012-02-13 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,935 0 owned after | $3.10 exercise price | 2012-02-15 | |
| 2012-02-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 7,000 owned after | $2.30 exercise price | 2012-02-07 | |
| 2012-02-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,285 3,286 owned after | $1.94 exercise price | 2012-02-07 | |
| 2012-02-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 3,750 owned after | $2.90 exercise price | 2012-02-07 | |
| 2012-02-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,935 1,935 owned after | $3.10 exercise price | 2012-02-07 | |
| 2012-01-20 | BAKER FELIX | BAKER JULIAN | 14159 capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +2 7 owned after | $1.50 | 2012-01-23 | |
| 2012-01-20 | BAKER FELIX | BAKER JULIAN | 14159 capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −5 2 owned after | $1.25 | 2012-01-23 | |
| 2012-01-20 | BAKER FELIX | BAKER JULIAN | 14159 capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −2 0 owned after | $1.50 | 2012-01-23 | |
| 2012-01-20 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +87 249 owned after | $1.50 | 2012-01-23 | |
| 2012-01-20 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −162 87 owned after | $1.25 | 2012-01-23 | |
| 2012-01-20 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −87 0 owned after | $1.50 | 2012-01-23 | |
| 2012-01-20 | BAKER JULIAN | Baker Biotech Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +16 44 owned after | $1.50 | 2012-01-23 | |
| 2012-01-20 | BAKER JULIAN | Baker Biotech Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −28 16 owned after | $1.25 | 2012-01-23 | |
| 2012-01-20 | BAKER JULIAN | Baker Biotech Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −16 0 owned after | $1.50 | 2012-01-23 | |
| 2012-01-19 | BAKER FELIX | BAKER JULIAN | 14159 capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +5 5 owned after | $1.25 | 2012-01-23 | |
| 2012-01-19 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +162 162 owned after | $1.25 | 2012-01-23 | |
| 2012-01-19 | BAKER JULIAN | Baker Biotech Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Call Option Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +28 28 owned after | $1.25 | 2012-01-23 | |
| 2012-01-07 | Fardis Maria Officer (EVP, Operations and Alliances) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 59,500 owned after | $6.84 exercise price | 2013-01-07 | |
| 2012-01-03 | van den Broek Richard Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,409 2,409 owned after | $15.02 exercise price | 2012-01-05 | |
| 2012-01-03 | Smith David Duane Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,480 2,480 owned after | $15.02 exercise price | 2012-01-05 | |
| 2012-01-03 | Mehta Minesh Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +973 973 owned after | $15.02 exercise price | 2012-01-05 | |
| 2012-01-03 | Hardiman Roy C. Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,963 1,963 owned after | $15.02 exercise price | 2012-01-05 | |
| 2012-01-03 | HALVORSON ERIC H Director | 4 | Non-qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +148 148 owned after | $15.02 exercise price | 2012-01-05 | |
| 2012-01-03 | Booth Robert F. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,754 1,754 owned after | $15.02 exercise price | 2012-01-05 |